vidutolimod,nivolumab
bms,checkmate pharmaceuticals
['nivolumab', 'nivo', 'vidutolimod']
coming up tonight at 6 pm presents phase ii trial with positive results combining vidutolimod &amp; nivolumab in melanoma. rm 258 abc. 